Medrol (Methylprednisolone)

• Medrol (methylprednisolone) is used to modulate inflammation and immune responses in several disease groups.
• Allergic reactions: reduces symptoms such as swelling, itching and airway constriction.
• Asthma: improves airway inflammation and helps prevent exacerbations.
• Rheumatoid arthritis: decreases joint inflammation and pain, slowing disease progression.
• Dermatologic inflammatory conditions: alleviates skin inflammation in conditions like eczema and psoriasis.
• Autoimmune diseases: suppresses abnormal immune activity in disorders such as systemic lupus erythematosus.

• Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and alters gene transcription. This modulation suppresses pro‑inflammatory cytokine production, reduces leukocyte migration, and stabilizes lysosomal membranes, resulting in potent anti‑inflammatory and immunosuppressive effects.

Methylprednisolone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Increased appetite and weight gain.
• Insomnia or mood changes.
• Elevated blood glucose levels.
• Gastrointestinal discomfort or dyspepsia.
• Fluid retention and mild hypertension.

Serious or Rare Side Effects

• Adrenal suppression leading to crisis.
• Severe infections, including opportunistic pathogens.
• Osteoporosis with long‑term use.
• Cataracts or glaucoma.
• Psychosis or severe mood disorders.
• Anaphylactic or severe allergic reactions.

• When prescribing methylprednisolone, clinicians should consider several safety measures to minimize risk.
• Assess infection risk: evaluate for active or latent infections before initiating therapy.
• Monitor blood glucose: check glucose levels regularly, especially in diabetic patients.
• Taper when discontinuing: gradually reduce dose to avoid adrenal insufficiency.
• Avoid in systemic fungal infection: contraindicated in patients with uncontrolled fungal disease.
• Use with caution in pregnancy: limited data; weigh benefits against potential risks.
• Store at room temperature: keep in original packaging, protect from moisture and heat.

Methylprednisolone can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase steroid levels.
• Live vaccines: risk of inadequate immune response or infection.
• Anticoagulants (e.g., warfarin): enhanced anticoagulant effect.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin) may reduce effectiveness.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of gastrointestinal bleeding.